Form 4: DENTSPLY SIRONA Officer Boosts Phantom Stock Holdings

DENTSPLY SIRONA's VP, Chief Accounting Officer, Kevin Czerney, increased his beneficial ownership of phantom stock through a Supplemental Executive Retirement Plan contribution.

Summary

• Kevin Czerney, VP, Chief Accounting Officer of DENTSPLY SIRONA Inc. (XRAY), acquired 2,853.551 shares of phantom stock.
• The transaction occurred on March 11, 2026.
• Each share of phantom stock is the economic equivalent of one share of common stock.
• The phantom stock becomes payable in common stock upon Mr. Czerney's termination of employment.
• This acquisition represents a Supplemental Executive Retirement Plan (SERP) contribution for the year 2025.
• The phantom stock was valued at $11.43 per share, based on the December 31, 2025 closing price.
• Following this transaction, Mr. Czerney beneficially owns a total of 6,346.9846 shares of phantom stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive, routine disclosure. While not directly impacting company financials, the increase in executive phantom stock holdings suggests continued alignment of management's long-term interests with shareholder value.

Positives

• The acquisition of phantom stock by a key executive, Kevin Czerney, aligns his long-term interests with those of shareholders, as the value is tied to the company's common stock performance.
• Participation in a Supplemental Executive Retirement Plan (SERP) is a common executive retention and incentive mechanism, indicating a commitment to long-term executive stability.

Future Outlook

The acquired phantom stock will become payable in common stock upon Kevin Czerney's termination of employment.

Industry Context

StockSavvy.ai notes that the use of phantom stock as part of a Supplemental Executive Retirement Plan (SERP) is a common practice in many industries, including the dental products and technologies sector, to provide long-term incentives and retain key executives. This type of compensation aligns executive interests with shareholder value over an extended period.

Comparison to Industry Standards

• The structure of this phantom stock grant, tied to a SERP and payable upon termination, is a standard executive compensation mechanism widely adopted across various industries, including healthcare and medical device companies like DENTSPLY SIRONA.
• Companies such as Stryker Corporation or Zimmer Biomet Holdings also utilize similar long-term incentive plans, often including phantom equity or restricted stock units, to retain top talent and incentivize performance over multi-year horizons.

Stakeholder Impact

• Shareholders: The transaction aligns the interests of a key executive with shareholders by tying a portion of his long-term compensation to the company's stock performance.
• Employees: This specific filing primarily impacts the named executive, Kevin Czerney, as part of his compensation package.

Next Steps

• The phantom stock will become payable in common stock upon Kevin Czerney's termination of employment.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Kevin Czerney, Phantom Stock, SERP, Executive Compensation, Insider Transaction, Form 4, Beneficial Ownership